142 related articles for article (PubMed ID: 16280455)
1. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
[TBL] [Abstract][Full Text] [Related]
2. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
Tanaka E; Kamata T; Katagi M; Tsuchihashi H; Honda K
Forensic Sci Int; 2006 Nov; 163(1-2):152-4. PubMed ID: 16406422
[TBL] [Abstract][Full Text] [Related]
3. A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry.
Jin MJ; Jin C; Kim JY; In MK; Kwon OS; Yoo HH
J Forensic Sci; 2011 Jul; 56(4):1044-8. PubMed ID: 21418218
[TBL] [Abstract][Full Text] [Related]
4. A foxy intoxication.
Wilson JM; McGeorge F; Smolinske S; Meatherall R
Forensic Sci Int; 2005 Feb; 148(1):31-6. PubMed ID: 15607587
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
6. Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry.
Yan X; Xiang P; Zhao Y; Yu Z; Yan H
J Anal Toxicol; 2020 Apr; 44(5):461-469. PubMed ID: 32020169
[TBL] [Abstract][Full Text] [Related]
7. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
[TBL] [Abstract][Full Text] [Related]
8. Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases.
Yan X; Yuan S; Yu Z; Zhao Y; Zhang S; Wu H; Yan H; Xiang P
J Forensic Leg Med; 2020 May; 72():101963. PubMed ID: 32452453
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Masuda K; Katsu T; Asanuma M; Kamata T; Katagi M; Tsuchihashi H; Kumamoto T; Ishikawa T; Naito S; Yamano S; Hanioka N
Biochem Pharmacol; 2008 Feb; 75(3):752-60. PubMed ID: 17980859
[TBL] [Abstract][Full Text] [Related]
10. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
Shulgin AT; Carter MF
Commun Psychopharmacol; 1980; 4(5):363-9. PubMed ID: 6949674
[No Abstract] [Full Text] [Related]
11. Application of hair analysis to document illegal 5-methoxy-N,N-dissopropyltrptamine (5-MeO-DiPT) use.
Wang R; Xiang P; Yu Z; Shi Y
Forensic Sci Int; 2019 Nov; 304():109972. PubMed ID: 31604205
[TBL] [Abstract][Full Text] [Related]
12. Foxy, a designer tryptamine hallucinogen.
Meatherall R; Sharma P
J Anal Toxicol; 2003; 27(5):313-7. PubMed ID: 12908946
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
Noworyta-Sokołowska K; Kamińska K; Kreiner G; Rogóż Z; Gołembiowska K
Neurotox Res; 2016 Nov; 30(4):606-619. PubMed ID: 27461536
[TBL] [Abstract][Full Text] [Related]
14. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
Vorce SP; Sklerov JH
J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
[TBL] [Abstract][Full Text] [Related]
15. Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry.
Ishida T; Kudo K; Kiyoshima A; Inoue H; Tsuji A; Ikeda N
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):47-52. PubMed ID: 16055053
[TBL] [Abstract][Full Text] [Related]
16. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
17. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
[TBL] [Abstract][Full Text] [Related]
18. Human Hepatocyte 4-Acetoxy-
Malaca S; Huestis MA; Lattanzio L; Marsella LT; Tagliabracci A; Carlier J; Busardò FP
Metabolites; 2022 Jul; 12(8):. PubMed ID: 36005577
[TBL] [Abstract][Full Text] [Related]
19. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
Noworyta-Sokołowska K; Górska AM; Gołembiowska K
Pharmacol Rep; 2018 Oct; 70(5):890-895. PubMed ID: 30096487
[TBL] [Abstract][Full Text] [Related]
20. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
Williams MT; Herring NR; Schaefer TL; Skelton MR; Campbell NG; Lipton JW; McCrea AE; Vorhees CV
Neuropsychopharmacology; 2007 Jun; 32(6):1404-20. PubMed ID: 17047665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
